T1	p 66 97	adults with autistic disorder .
T2	p 374 400	some persons with autism .
T3	p 508 544	Thirty adults with autistic disorder
T4	p 1562 1591	autistic disorder in adults .
T5	p 1703 1741	children and adolescents with autism .
T6	i 23 41	placebo-controlled
T7	i 580 598	placebo-controlled
T8	i 907 914	placebo
T9	i 964 971	placebo
T10	i 1472 1483	Fluvoxamine
T11	i 1507 1514	placebo
T12	o 975 1016	reducing repetitive thoughts and behavior
T13	o 1260 1334	autistic behavior , or full-scale IQ . Other than mild sedation and nausea
T14	o 1376 1459	tolerated . No dyskinesias , adverse cardiovascular events , or seizures occurred .